Bridge Point Capital

Bridge Point Capital is a multi-family office located in New York, specializing in investment opportunities within the healthcare sector. The firm aims to connect like-minded investors with innovative companies that are driving significant advancements in healthcare, ultimately contributing to societal change and wealth creation. Through its focus on cutting-edge innovations, Bridge Point Capital seeks to identify and capitalize on potential investments that have the capacity to transform the industry.

Nadia Xiaowan Tian

Co-Founder, Co-CEO and Founding Partner

Mark Young

Co-Founder, Co-CEO and Chief Investment Officer

2 past transactions

CurioInvest

Venture Round in 2024
Curio is a digital asset investment platform specializing in the tokenization of collectible and rare cars. By leveraging blockchain technology, particularly on networks like Ethereum, Curio aims to simplify the investment process in this lucrative asset class, which has outperformed traditional financial indices since 2008. The company provides an innovative solution that eliminates high capital requirements, making it more accessible for a wider range of investors to participate in the collectible car market. Curio's mission focuses on pioneering the adoption of distributed ledger technologies in the automotive sector, enabling individuals to invest directly in prestigious vehicles without the need for costly intermediaries. Through its analytics engine and tailored approaches, Curio seeks to revolutionize how people engage with and invest in high-value collectibles.

Clerio Vision

Venture Round in 2021
Clerio Vision is a medical device company based in Rochester, New York, established in 2014. It focuses on developing innovative contact lenses that aim to address safety and performance challenges associated with traditional refractive surgery. The company utilizes laser-induced refractive index correction technology, which has the potential to transform the vision correction market by allowing physicians to effectively treat refractive index issues in the human cornea. Clerio Vision is actively engaged in the commercialization of its next-generation products, positioning itself as a key player in the ophthalmic medical device sector.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.